| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Drug evaluation: Degarelix--a potential new therapy for prostate cancer. | IDrugs | 2006 | 0.82 |
| 2 | Cytokine and vaccine therapy of kidney cancer. | Expert Rev Anticancer Ther | 2004 | 0.77 |
| 3 | Technology evaluation: MLN-591, Cornell University/BZL Biologics/ImmunoGen/Millennium. | Curr Opin Mol Ther | 2002 | 0.75 |
| 4 | Results of secondary ureteral implantation after kidney transplantation. | Int Urol Nephrol | 2011 | 0.75 |